Literature DB >> 8701751

Pharmacokinetics of tablet huperzine A in six volunteers.

B C Qian1, M Wang, Z F Zhou, K Chen, R R Zhou, G S Chen.   

Abstract

AIM: To study pharmacokinetics of tablet huperzine A (Hup-A) in Chinese volunteers to help establishing its drug administration schedule.
METHODS: For 6 volunteers after a single oral dose of 0.99 mg, drug concentrations in plasma were assayed by reverse phase high pressure liquid chromatography (HPLC) at 0.5, 0.75, 1.0, 1.25, 1.5, 2, 4, 6, 8, and 10 h. The pharmacokinetic parameters were calculated with a 3P87 program by computer.
RESULTS: The time course of plasma concentrations conformed to a one-compartment open model with a first order absorption. The pharmacokinetic parameters were as follows: T 1/2ka = 12.6 min, T 1/2ke = 288.5 min, Tmax = 79.6 min, Cmax = 8.4 micrograms L-1, AUC = 4.1 mg L-1 min.
CONCLUSION: Hup-A was absorbed rapidly, distributed widely in the body, and eliminated at a moderate rate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8701751

Source DB:  PubMed          Journal:  Zhongguo Yao Li Xue Bao        ISSN: 0253-9756


  9 in total

1.  Pharmacokinetics of huperzine A following oral administration to human volunteers.

Authors:  Y X Li; R Q Zhang; C R Li; X H Jiang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Oct-Dec       Impact factor: 2.441

2.  The combination of huperzine A and imidazenil is an effective strategy to prevent diisopropyl fluorophosphate toxicity in mice.

Authors:  Fabio Pibiri; Alan P Kozikowski; Graziano Pinna; James Auta; Bashkim Kadriu; Erminio Costa; Alessandro Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-10       Impact factor: 11.205

3.  Population pharmacokinetic modeling and simulation of huperzine A in elderly Chinese subjects.

Authors:  Lei Sheng; Yi Qu; Jing Yan; Gang-Yi Liu; Wei-Liang Wang; Yi-Jun Wang; Hong-Yi Wang; Meng-Qi Zhang; Chuan Lu; Yun Liu; Jing-Yin Jia; Chao-Ying Hu; Xue-Ning Li; Chen Yu; Hong-Rong Xu
Journal:  Acta Pharmacol Sin       Date:  2016-05-16       Impact factor: 6.150

4.  Pharmacokinetics and tolerability of oral dosage forms of huperzine a in healthy Chinese male volunteers: a randomized, single dose, three-period, six-sequence crossover study.

Authors:  San-Lan Wu; Jun Gan; Jing Rao; Si-Jie He; Wen-Wen Zhu; Ying Zhao; Yong-Ning Lv; Jian-Geng Huang; Ya-Ni Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

5.  Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect.

Authors:  Niloufar Ansari; Fariba Khodagholi
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

6.  Synergistic Effect and Mechanism of Cineole and Terpineol on In-vitro Transdermal Delivery of Huperzine A from Microemulsions.

Authors:  Jun Shi; Wen-Juan Cong; Yi-Ming Wang; Qing-Fei Liu; Guo-An Luo
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

7.  De novo RNA sequencing and transcriptome analysis of Colletotrichum gloeosporioides ES026 reveal genes related to biosynthesis of huperzine A.

Authors:  Guowei Zhang; Wenjuan Wang; Xiangmei Zhang; Qianqian Xia; Xinmei Zhao; Youngjoon Ahn; Nevin Ahmed; Andreea Cosoveanu; Mo Wang; Jialu Wang; Shaohua Shu
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

8.  Ethanol and methanol can improve huperzine A production from endophytic Colletotrichum gloeosporioides ES026.

Authors:  Xin-Mei Zhao; Zhang-Qian Wang; Shao-Hua Shu; Wen-Juan Wang; Hai-Jie Xu; Young-Joon Ahn; Mo Wang; Xuebo Hu
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

9.  Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder.

Authors:  Richard De La Garza; Christopher D Verrico; Thomas F Newton; James J Mahoney; Daisy G Y Thompson-Lake
Journal:  Int J Neuropsychopharmacol       Date:  2015-09-12       Impact factor: 5.176

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.